Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Biomaterials ; 35(10): 3281-97, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24461327

ABSTRACT

Acellular whole human lung scaffolds represent a unique opportunity for ex vivo tissue engineering. However, it remains unclear whether lungs from individuals with chronic lung diseases such as chronic obstructive pulmonary disease (COPD) can be appropriately decellularized and recellularized. To assess this, cadaveric human lungs from normal (non-smoking) patients and from patients with COPD (smoking history) were decellularized and found by histochemical and immunohistochemical staining, electron microscopy, and mass spectrometry to retain characteristic histological architecture and extracellular matrix components (ECM) reflecting either normal or COPD, particularly emphysematous, origin. Inoculation of human bronchial epithelial cells, endothelial progenitor cells, bone marrow-derived mesenchymal stem cells, and lung fibroblasts via airway or vascular routes into small, excised segments of the decellularized lungs demonstrated that normal lung scaffolds robustly supported initial engraftment and growth of each cell type for up to one month. In contrast, despite initial binding, all cell types inoculated into decellularized emphysematous lungs did not survive beyond one week. However, cell attachment and proliferation on solubilized ECM homogenates of decellularized normal and emphysematous lungs coated onto tissue culture plates was comparable and not impaired, suggesting that the 3-dimensional decellularized emphysematous scaffolds may lack the necessary ECM architecture to support sustained cell growth.


Subject(s)
Emphysema/pathology , Lung/pathology , Cell Line , Extracellular Matrix Proteins/metabolism , Humans , Mass Spectrometry , Microscopy, Electron
2.
Biomaterials ; 35(9): 2664-79, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24411675

ABSTRACT

Acellular scaffolds from complex whole organs such as lung are being increasingly studied for ex vivo organ generation and for in vitro studies of cell-extracellular matrix interactions. We have established effective methods for efficient de and recellularization of large animal and human lungs including techniques which allow multiple small segments (∼ 1-3 cm(3)) to be excised that retain 3-dimensional lung structure. Coupled with the use of a synthetic pleural coating, cells can be selectively physiologically inoculated via preserved vascular and airway conduits. Inoculated segments can be further sliced for high throughput studies. Further, we demonstrate thermography as a powerful noninvasive technique for monitoring perfusion decellularization and for evaluating preservation of vascular and airway networks following human and porcine lung decellularization. Collectively, these techniques are a significant step forward as they allow high throughput in vitro studies from a single lung or lobe in a more biologically relevant, three-dimensional acellular scaffold.


Subject(s)
Lung Diseases/physiopathology , Lung/pathology , Lung/physiopathology , Regeneration , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Animals , Cadaver , Endothelial Cells/cytology , Epithelial Cells/cytology , Extracellular Matrix/metabolism , Fibroblasts/cytology , Humans , Infrared Rays , Lung/ultrastructure , Lung Diseases/pathology , Mass Spectrometry , Mesenchymal Stem Cells/cytology , Perfusion , Sus scrofa , Thermography
3.
Stem Cells Transl Med ; 3(2): 194-205, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24436442

ABSTRACT

Systemic administration of mesenchymal stromal cells (MSCs) suppresses airway inflammation and methacholine-induced airway hyper-responsiveness (AHR) in mouse models of T helper cell (Th) type 2-mediated eosinophilic allergic airway inflammation (AAI); however, the efficacy of MSCs in mouse models of severe Th17-mediated neutrophilic AAI has not yet been demonstrated. We assessed MSC effects in a mouse model of mixed Th2/Th17 AAI produced by mucosal exposure to Aspergillus fumigatus hyphal extract (AHE). Following sensitization produced by oropharyngeal AHE administration, systemic (tail vein) administration of syngeneic MSCs on the first day of challenge significantly reduced acute AHR predominantly through reduction of Th17-mediated airway inflammation. In parallel experiments, MSCs also mitigated AHR when administered during recurrent challenge 10 weeks after initial sensitization and challenge through reduction in systemic Th17-mediated inflammation. Investigation into potential mechanistic actions of MSCs in this model demonstrated that although T regulatory cells were increased in all AHE-treated mice, MSC administration did not alter T regulatory cell numbers in either the acute or recurrent model. Differential induction of interleukin-17a secretion was observed in ex vivo restimulation of mediastinal lymph node mixed-cell cytokine analyses. Although the mechanisms by which MSCs act to decrease inflammation and AHR in this model are not yet fully elucidated, decrease in Th17-mediated airway inflammation appears to play a significant role. These results provide a basis for further investigations of MSC administration as a potential therapeutic approach for severe refractory neutrophilic asthma.


Subject(s)
Aspergillosis, Allergic Bronchopulmonary/immunology , Aspergillosis, Allergic Bronchopulmonary/therapy , Aspergillus fumigatus/immunology , Mesenchymal Stem Cells/microbiology , Signal Transduction/immunology , Th17 Cells/microbiology , Animals , Aspergillosis, Allergic Bronchopulmonary/metabolism , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Disease Models, Animal , Interleukin-17/immunology , Interleukin-17/metabolism , Lymph Nodes/immunology , Lymph Nodes/microbiology , Lymphocyte Culture Test, Mixed , Male , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/immunology , Mice , Mice, Inbred C57BL , Neutrophils/immunology , Neutrophils/metabolism , Neutrophils/microbiology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , T-Lymphocytes, Regulatory/microbiology , Th17 Cells/immunology , Th17 Cells/metabolism
4.
Gastroenterology ; 142(4): 844-854.e4, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22226658

ABSTRACT

BACKGROUND & AIMS: 5-hydroxytryptamine receptor (5-HT(4)R) agonists promote gastrointestinal motility and attenuate visceral pain, but concerns about adverse reactions have restricted their availability. We tested the hypotheses that 5-HT(4) receptors are expressed in the colonic epithelium and that 5-HT(4)R agonists can act intraluminally to increase motility and reduce visceral hypersensitivity. METHODS: Mucosal expression of the 5-HT(4)R was evaluated by reverse-transcriptase polymerase chain reaction and immunohistochemical analysis of tissues from 5-HT(4)R(BAC)-enhanced green fluorescent protein mice. Amperometry, histology, and short-circuit current measurements were used to study 5-HT, mucus, and Cl(-) secretion, respectively. Propulsive motility was measured in guinea pig distal colon, and visceromotor responses were recorded in a rat model of colonic hypersensitivity. 5-HT(4)R compounds included cisapride, tegaserod, naronapride, SB204070, and GR113808. RESULTS: Mucosal 5-HT(4) receptors were present in the small and large intestines. In the distal colon, 5-HT(4) receptors were expressed by most epithelial cells, including enterochromaffin and goblet cells. Stimulation of 5-HT(4)Rs evoked mucosal 5-HT release, goblet cell degranulation, and Cl(-) secretion. Luminal administration of 5-HT(4)R agonists accelerated propulsive motility; a 5-HT(4)R antagonist blocked this effect. Bath application of 5-HT(4)R agonists did not affect motility. Oral or intracolonic administration of 5-HT(4)R agonists attenuated visceral hypersensitivity. Intracolonic administration was more potent than oral administration, and was inhibited by a 5-HT(4)R antagonist. CONCLUSIONS: Mucosal 5-HT(4) receptor activation can mediate the prokinetic and antinociceptive actions of 5-HT(4)R agonists. Colon-targeted, intraluminal delivery of 5-HT(4)R agonists might be used to promote motility and alleviate visceral pain, while restricting systemic bioavailability and resulting adverse side effects.


Subject(s)
Analgesics/pharmacology , Colon/drug effects , Gastrointestinal Agents/pharmacology , Gastrointestinal Motility/drug effects , Hyperalgesia/prevention & control , Intestinal Mucosa/drug effects , Pain/prevention & control , Receptors, Serotonin, 5-HT4/drug effects , Serotonin 5-HT4 Receptor Agonists/pharmacology , Administration, Oral , Analgesics/administration & dosage , Animals , Chlorides/metabolism , Chromosomes, Artificial, Bacterial , Colon/innervation , Colon/metabolism , Disease Models, Animal , Enterochromaffin Cells/drug effects , Enterochromaffin Cells/metabolism , Gastrointestinal Agents/administration & dosage , Goblet Cells/drug effects , Goblet Cells/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Guinea Pigs , Humans , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Immunohistochemistry , Intestinal Mucosa/innervation , Intestinal Mucosa/metabolism , Male , Membrane Potentials , Mice , Mice, Inbred BALB C , Mice, Transgenic , Mucus/metabolism , Pain/metabolism , Pain/physiopathology , Pain Threshold/drug effects , Pressure , Rats , Rats, Sprague-Dawley , Receptors, Serotonin, 5-HT4/genetics , Receptors, Serotonin, 5-HT4/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Serotonin/metabolism , Serotonin 5-HT4 Receptor Agonists/administration & dosage
5.
J Vis Exp ; (46)2010 Dec 01.
Article in English | MEDLINE | ID: mdl-21189461

ABSTRACT

The Gastrointestinal Motility Monitor (GIMM; Catamount Research and Development; St. Albans, VT) is an in vitro system that monitors propulsive motility in isolated segments of guinea pig distal colon. The complete system consists of a computer, video camera, illuminated organ bath, peristaltic and heated water bath circulating pumps, and custom GIMM software to record and analyze data. Compared with traditional methods of monitoring colonic peristalsis, the GIMM system allows for continuous, quantitative evaluation of motility. The guinea pig distal colon is bathed in warmed, oxygenated Krebs solution, and fecal pellets inserted in the oral end are propelled along the segment of colon at a rate of about 2 mm/sec. Movies of the fecal pellet proceeding along the segment are captured, and the GIMM software can be used track the progress of the fecal pellet. Rates of propulsive motility can be obtained for the entire segment or for any particular region of interest. In addition to analysis of bolus-induced motility patterns, spatiotemporal maps can be constructed from captured video segments to assess spontaneous motor activity patterns. Applications of this system include pharmacological evaluation of the effects of receptor agonists and antagonists on propulsive motility, as well as assessment of changes that result from pathophysiological conditions, such as inflammation or stress. The guinea pig distal colon propulsive motility assay, using the GIMM system, is straightforward and simple to learn, and it provides a reliable and reproducible method of assessing propulsive motility.


Subject(s)
Colon/physiology , Gastrointestinal Motility/physiology , Monitoring, Physiologic/instrumentation , Animals , Guinea Pigs , In Vitro Techniques , Monitoring, Physiologic/methods
6.
Gastroenterology ; 139(1): 249-58, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20303355

ABSTRACT

BACKGROUND & AIMS: In adults, irritable bowel syndrome (IBS) and functional dyspepsia (FD) are chronic conditions that often start during childhood. We investigated mucosal serotonin (5-HT) signaling in children with the idea that data from subjects with a shorter history may improve our understanding of underlying pathophysiological mechanisms. METHODS: Ninety-eight children undergoing gastroscopy or colonoscopy were studied prospectively. Biopsy specimens were evaluated for inflammation, enterochromaffin cell numbers, 5-HT content, and messenger RNA (mRNA) levels for the synthetic enzyme, tryptophan hydroxylase 1, and the serotonin transporter (SERT) were assessed by quantitative real-time reverse-transcription polymerase chain reaction. RESULTS: Data from 12 children with IBS and 17 with FD were compared with age-matched controls (12 with rectal biopsies and 12 with gastric biopsies) and with subjects with organic disorders. In patients with FD, a small number of immune cells were observed in the gastric mucosa in half of the patients, but no abnormalities with respect to the 5-HT pathway were identified. In patients with IBS, no differences were detected between patients and controls regarding intraepithelial lymphocytes and CD3+ cells in the lamina propria although all patients showed at least a slight inflammatory infiltrate. In the IBS samples, higher 5-HT content (P < .01) and lower SERT mRNA (P < .05) were detected as compared with controls. Severe inflammation in the colonic mucosa had a high impact on 5-HT signaling with a significant decrease in enterochromaffin cells (P < .01) and 5-HT content (P < .01) and a high SERT mRNA expression (P < .01). CONCLUSIONS: These results confirm the role of 5-HT signaling in IBS in children and argue against such a role in FD.


Subject(s)
Diarrhea/metabolism , Dyspepsia/metabolism , Irritable Bowel Syndrome/metabolism , Serotonin/physiology , Signal Transduction/physiology , Adolescent , Child , Female , Humans , Male , Octamer Transcription Factor-1/genetics , RNA, Messenger/analysis , Serotonin/analysis , Serotonin/genetics , Serotonin Plasma Membrane Transport Proteins/genetics , Tryptophan Hydroxylase/genetics
7.
Am J Gastroenterol ; 105(5): 1173-80, 2010 May.
Article in English | MEDLINE | ID: mdl-20010921

ABSTRACT

OBJECTIVES: Changes in mucosal serotonin (5-HT) signaling have been detected in a number of functional and inflammatory disorders of the gastrointestinal (GI) tract. This study was undertaken to determine whether chronic constipation (CC) is associated with disordered 5-HT signaling and to evaluate whether constipation caused by opiate use causes such changes. METHODS: Human rectal biopsy samples were obtained from healthy volunteers, individuals with idiopathic CC, and individuals taking opiate medication with or without occurrence of constipation. EC cells were identified by 5-HT immunohistochemistry. 5-HT content and release levels were determined by enzyme immunoassay, and mRNA levels for the synthetic enzyme tryptophan hydroxylase-1 (TpH-1) and serotonin-selective reuptake transporter (SERT) were assessed by quantitative real-time reverse transcription PCR. RESULTS: CC was associated with increases in TpH-1 transcript, 5-HT content, and 5-HT release under basal and stimulated conditions, whereas EC cell numbers and SERT transcript levels were not altered. No changes in these elements of 5-HT signaling were detected in opiate-induced constipation (OIC). CONCLUSIONS: These findings demonstrate that CC is associated with a pattern of altered 5-HT signaling that leads to increased 5-HT availability but does not involve a decrease in SERT expression. It is possible that increased 5-HT availability due to increased synthesis and release contributes to constipation due to receptor desensitization. Furthermore, the finding that elements of 5-HT signaling were not altered in the mucosa of individuals with OIC indicates that constipation as a condition does not lead to compensatory changes in 5-HT synthesis, release, or signal termination.


Subject(s)
Analgesics, Opioid/adverse effects , Constipation/etiology , Constipation/pathology , Serotonin/metabolism , Adult , Aged , Analgesics, Opioid/therapeutic use , Analysis of Variance , Biopsy, Needle , Case-Control Studies , Chronic Disease , Enzyme-Linked Immunosorbent Assay , Female , Genetic Markers , Humans , Immunohistochemistry , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Middle Aged , Probability , RNA, Messenger/analysis , Reference Values , Reverse Transcriptase Polymerase Chain Reaction , Serotonin/genetics , Serotonin Plasma Membrane Transport Proteins/genetics , Serotonin Plasma Membrane Transport Proteins/metabolism , Severity of Illness Index , Signal Transduction , Young Adult
8.
Mutat Res ; 615(1-2): 12-7, 2007 Feb 03.
Article in English | MEDLINE | ID: mdl-17207504

ABSTRACT

Folic acid deficiency (FA-) augments DNA damage caused by alkylating agents. The role of DNA repair in modulating this damage was investigated in mice. Weanling wild-type or 3-methyladenine glycosylase (Aag) null mice were maintained on a FA- diet or the same diet supplemented with folic acid (FA+) for 4 weeks. They were then treated with methyl methanesulfonate (MMS), 100mg/kg i.p. Six weeks later, spleen cells were collected for assays of non-selected and 6-thioguanine (TG) selected cloning efficiency to measure the mutant frequency at the Hprt locus. In wild-type mice, there was no significant effect of either MMS treatment or folate dietary content on splenocyte non-selected cloning efficiency. In contrast, non-selected cloning efficiency was significantly higher in MMS-treated Aag null mice than in saline treated controls (diet-gene interaction variable, p=0.04). The non-selected cloning efficiency was significantly higher in the FA+ diet than in the FA- diet group after MMS treatment of Aag null mice. Mutant frequency after MMS treatment was significantly higher in FA- wild-type and Aag null mice and in FA+ Aag null mice, but not in FA+ wild-type mice. For the Aag null mice, mutant frequency was higher in the FA+ mice than in the FA- mice after either saline or MMS treatment. These studies indicate that in wild-type mice treated with MMS, dietary folate content (FA+ or FA-) had no effect on cytotoxicity, but FA- diet increased DNA mutation frequency compared to FA+ diet. In Aag null mice, FA- diet increased the cytotoxic effects of alkylating agents but decreased the risk of DNA mutation.


Subject(s)
DNA Glycosylases/deficiency , Folic Acid Deficiency/genetics , Folic Acid Deficiency/metabolism , Methyl Methanesulfonate/toxicity , Mutagens/toxicity , Animals , Antineoplastic Agents, Alkylating/toxicity , Colony-Forming Units Assay , DNA Glycosylases/genetics , Folic Acid Deficiency/pathology , Hypoxanthine Phosphoribosyltransferase/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mutation , Spleen/drug effects , Spleen/pathology
9.
Transl Res ; 148(6): 315-24, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17162253

ABSTRACT

Dietary supplements are used by most patients with cancer. As nutraceuticals can interact with many drugs, this study investigated the effect of herbal remedies and vitamins on the toxicity of representative cancer chemotherapeutic agents. Fisher 344 rats were fed a standard cereal-based diet or the same diet with additional vitamin E in low (50 mg/kg) or high (750 mg/kg) concentrations, or with added St. John's wort (400 mg/kg). The LD50 was determined after the administration of chemotherapy drugs. Neither low or high vitamin E supplements nor St. John's wort significantly changed the LD50 for doxorubicin, docetaxel, or cyclophosphamide. The nadir white blood cell (WBC) count was significantly higher (P = 0.004) after docetaxel in rats supplemented with low-dose vitamin E, but the drop in WBC count from initial to nadir levels (Nfall) was greater in rats fed a diet containing high vitamin E supplementation (P = 0.04). Similarly, the Nfall was greater in the standard and high vitamin E dietary groups than in the low vitamin E group after cyclophosphamide (P = 0.03). No effect of vitamin E or St. John's wort supplementation occurred on doxorubicin pharmacokinetics. Neither vitamin E nor St. John's wort had an important effect on the mitochondrial deoxyribonucleic acid (DNA) damage caused by either doxorubicin or docetaxel. These data suggest that the leucopenia caused by some chemotherapeutic agents can be modified by dietary supplementation with vitamin E, but the effect seems to be dose-dependent. St. John's wort had neither a beneficial nor a detrimental effect on chemotherapy-induced toxicity.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/toxicity , Hypericum , Leukopenia/drug therapy , Plant Preparations/administration & dosage , Vitamin E/administration & dosage , Animals , Cyclophosphamide/toxicity , DNA Damage , DNA, Mitochondrial/drug effects , Diet , Docetaxel , Dose-Response Relationship, Drug , Doxorubicin/pharmacokinetics , Doxorubicin/toxicity , Female , Leukocyte Count , Leukopenia/chemically induced , Phytotherapy , Rats , Rats, Inbred F344 , Taxoids/toxicity
10.
Environ Mol Mutagen ; 44(4): 313-20, 2004.
Article in English | MEDLINE | ID: mdl-15476199

ABSTRACT

Changes in mitochondrial DNA copy number and increases in mitochondrial DNA mutations, especially deletions, have been associated with exposure to mutagens and with aging. Common deletions that are the result of recombination between direct repeats in human and rat (4,977 and 4,834, bp, respectively) are known to increase in tissues of aged individuals. Previous studies have used long-distance PCR and Southern blot or quantitative PCR to determine the frequency of deleted mitochondrial DNA. A quantitative PCR (TaqMan) assay was developed to detect both mitochondrial DNA copy number and deletion frequency in the rat. This methodology allows not only the determination of changes in the amount of mitochondrial DNA deletion relative to total mitochondrial DNA but also to determine changes in total mitochondrial DNA relative to genomic DNA. As a validation of the assay in rat liver, the frequency of the common 4,834 bp deletion is shown to increase with age, while the relative mitochondrial DNA copy number rises at a young age (3-60 days), then decreases and holds fairly steady to 2 years of age.


Subject(s)
DNA, Mitochondrial/genetics , Gene Deletion , Polymerase Chain Reaction/methods , Rats/genetics , Age Factors , Animals , DNA Primers , DNA, Mitochondrial/metabolism , Liver/metabolism
11.
Cancer ; 101(5): 1058-64, 2004 Sep 01.
Article in English | MEDLINE | ID: mdl-15329916

ABSTRACT

BACKGROUND: Although patients with malignant disease frequently use dietary supplements, the effects of these agents with regard to chemotherapy are unclear. Therefore, the authors investigated the influence of vitamin B12, folate, and nutritional supplements on chemotherapy-induced toxicity. METHODS: Women with breast carcinoma were asked to complete a questionnaire that recorded their use of dietary supplements. Blood samples were obtained for the assessment of serum vitamin B12 and folate levels before and after the first cycle of chemotherapy and for weekly complete blood counts. Toxicity was evaluated by measuring absolute neutrophil counts and the frequency and severity of oral mucositis. RESULTS: Of the 49 women who submitted questionnaires, 35 (71%) took a combined total of 165 supplements. Compared with patients in a previous study (performed in 1990), patients in the current study had dramatically increased serum folate levels. Initial neutrophil count, but not type of chemotherapy, patient age, or serum vitamin B12 level, was predictive of nadir absolute neutropenia and the decrease from initial neutrophil count to nadir (Nfall). After adjusting for initial neutrophil count, Nfall was found to be lower for women who were taking supplements compared with women who were not taking supplements (P = 0.01) and for women who were taking multivitamins (P = 0.01) or vitamin E (P = 0.03). Women with serum folic acid levels < 20 ng/mL had a smaller decrease in neutrophil count after chemotherapy than did women with higher folate levels (P = 0.04). No significant association between oral mucositis and initial neutrophil count, nadir neutrophil count, Nfall, age, vitamin B12 level, or folate level was found. CONCLUSIONS: The decrease in neutrophil count caused by chemotherapy was ameliorated by dietary supplementation with a multivitamin or vitamin E. In contrast, high serum folate levels were associated with the exacerbation of this decrease in neutrophil count.


Subject(s)
Antineoplastic Agents/adverse effects , Breast Neoplasms/drug therapy , Dietary Supplements , Folic Acid/administration & dosage , Mucous Membrane/drug effects , Neutropenia/prevention & control , Vitamin B 12/administration & dosage , Adult , Aged , Antioxidants/therapeutic use , Breast Neoplasms/blood , Breast Neoplasms/prevention & control , Female , Humans , Leukocyte Count , Middle Aged , Neutropenia/chemically induced , Neutrophils , Surveys and Questionnaires , Vitamin B 12/blood
12.
J Lab Clin Med ; 140(5): 358-68, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12434138

ABSTRACT

The effects of diet and folate status on cyclophosphamide or 5-fluorouracil toxicity were studied in Fischer 344 rats maintained on either a cereal-based diet or a purified diet (AIN-93G). The rats fed the purified diet were divided into 3 groups: folate deficient (no dietary folic acid), folate replete (2 mg folic acid/kg diet), and high folate (2 mg folic acid/kg diet plus 50 mg/kg body weight folic acid intraperitoneally daily). The LD50 for cyclophosphamide was significantly higher for the cereal diet than for the purified diets, but there was no difference among the purified diets. Deaths were predicted by dose, diet, white blood cell count, and BUN on Day 4 after treatment. In the saline-treated rats fed the purified diet, hepatic total glutathione levels increased in the following order: folate deficient < folate replete < high folate. There was no significant difference in aldehyde dehydogenase activities or of microsomal P450 levels in livers from rats on the different diets. In the rats treated with 5-fluorouracil, the high folate rats developed more severe anemia, azotemia, and leukopenia than the other groups. Weight, white blood cell count, hematocrit, and BUN were important predictors of death. The kidneys from rats fed the cereal-based diet were histologically normal, but rats ingesting the purified diet had increasing renal pathology that correlated with folate intake. These results indicate that diet has an important influence on the toxicity of cyclophosphamide and 5-fluorouracil and that folate status modulates hepatic glutathione levels, which is a major cellular defense against oxidant and alkylating agent damage.


Subject(s)
Antimetabolites, Antineoplastic/toxicity , Cyclophosphamide/toxicity , Diet , Fluorouracil/toxicity , Folic Acid/administration & dosage , Animal Feed , Animals , Dietary Supplements , Dose-Response Relationship, Drug , Female , Folic Acid/physiology , Glutathione/metabolism , Kidney/drug effects , Kidney/pathology , Lethal Dose 50 , Liver/drug effects , Liver/metabolism , Longevity/drug effects , Nutritional Status/drug effects , Rats , Rats, Inbred F344
13.
Comp Med ; 52(4): 359-62, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12211281

ABSTRACT

Rats fed either a cereal-based or purified diet of variable folate content (deficient, replete, or supplemented) inadvertently were infected with sialodacryoadenitis virus, which resulted in an increased frequency of hepatic mitochondrial DNA (mtDNA) deletions that persisted for three weeks after the period of acute signs of disease. The amount of the "common deletion" (4.8 kb, bases 8103-12937) in liver was measured by quantitative co-amplification of the mitochondrial D-loop and the mitochondrial deletion, using a real-time quantitative polymerase chain reaction assay. The relative abundance of mtDNA was determined by co-amplifying mitochondrial D-loop versus the rat beta-actin gene. Virus-infected rats had more mtDNA deletions (P < 0.0001) and higher copy number (P < 0.0001) than did uninfected animals. There was no effect of diet on frequency of deletions. Diet affected mtDNA relative abundance in the infected, but not the uninfected rats. Relative abundance was higher (P = 0.004) in rats of the high folate group than in rats of the low-folate or folate-replete groups, and was significantly higher in rats of the cereal diet group than that in those of the purified diet group. In conclusion, sialodacryoadenitis virus infection in rats was associated with increased frequency of hepatic mtDNA deletions. Thus, sialodacryoadenitis virus infection mitigated biological processes in the liver of rats, and mtDNA damage was modulated by diet.


Subject(s)
Coronavirus Infections/veterinary , DNA, Mitochondrial/genetics , Diet , Liver/physiology , Rodent Diseases/genetics , Sequence Deletion , Animals , Coronavirus/physiology , Coronavirus Infections/genetics , Coronavirus Infections/virology , Female , Folic Acid/administration & dosage , Rats , Rodent Diseases/virology
14.
Mutat Res ; 501(1-2): 29-36, 2002 Apr 25.
Article in English | MEDLINE | ID: mdl-11934435

ABSTRACT

Mitochondrial DNA (mtDNA) is particularly susceptible to mutation by alkylating agents, and mitochondrial damage may contribute to the efficacy and toxicity of these agents. We found that folate supplementation decreased the frequency of the "common deletion" (4.8kb, bases 8103-12,936) in liver from untreated rats and from animals treated with cyclophosphamide but not 5-fluorouracil (5-FU). The relative abundance of mitochondrial DNA was greater after chemotherapy but there was no effect of diet. Rats fed with a purified diet had fewer mitochondrial deletions than those maintained on a cereal-based diet after chemotherapy. These results indicate that diet can modulate the extent of mitochondrial damage after cancer chemotherapy, and that folic acid supplementation may be protective against mitochondrial DNA deletions.


Subject(s)
Antineoplastic Agents/adverse effects , DNA, Mitochondrial , Folic Acid/administration & dosage , Gene Dosage , Sequence Deletion/drug effects , Alkylating Agents/adverse effects , Animals , Cyclophosphamide/adverse effects , Diet , Female , Fluorouracil/adverse effects , Mitochondria, Liver/drug effects , Mitochondria, Liver/genetics , Rats , Rats, Inbred F344
SELECTION OF CITATIONS
SEARCH DETAIL
...